SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001697884-20-000025
Filing Date
2020-09-28
Accepted
2020-09-28 09:20:02
Documents
42
Period of Report
2020-07-31

Document Format Files

Seq Description Document Type Size
1 vsbc10qjuly2020.htm 10-Q 301075
2 ex311.htm EX-31.1 20461
3 ex312.htm EX-31.2 20456
4 ex321.htm EX-32.1 6745
5 ex322.htm EX-32.2 6745
  Complete submission text file 0001697884-20-000025.txt   1517816

Data Files

Seq Description Document Type Size
6 none-20200731.xml EX-101.INS 251914
7 none-20200731.xsd EX-101.SCH 16458
8 none-20200731_cal.xml EX-101.CAL 2582
9 none-20200731_def.xml EX-101.DEF 14363
10 none-20200731_lab.xml EX-101.LAB 151016
11 none-20200731_pre.xml EX-101.PRE 84555
Mailing Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618 13239854212
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 201202294
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services